Home > PE Ratio > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of BALAXI PHARMACEUTICALS is 92.57.

Share Price ₹23.7Jul 01,2026
Market Cap ₹131.0 Cr
Earnings-TTM₹1.4 CrTTM-Consolidated Results
Price/Earnings92.57xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BALAXI PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹131.0 Cr] as on Jul 01,2026

(/) Earnings [ ₹1.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 92.57x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 92.57 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS


PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS

- BALAXI PHARMACEUTICALS 's latest p/e ratio is 92.57x.

- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.25x.

- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 7.3x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.

- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BALAXI PHARMACEUTICALS 1.4292.57131.0
ADANI ENTERPRISES LTD9,693.5142.21409,155.0
PREMIER ENERGIES LTD1,504.5731.7147,717.1
ADITYA INFOTECH LTD367.96114.4342,107.4
AEGIS LOGISTICS LTD1,106.6339.7643,999.6
REDINGTON LTD1,284.1516.6721,408.9
RRP SEMICONDUCTOR LTD-7.75-1,578.5812,240.3
HONASA CONSUMER LTD200.3375.9415,213.9
LLOYDS ENTERPRISES LTD374.5330.0511,255.3
MMTC LTD212.0747.8610,150.5
CELLO WORLD LTD331.5124.358,073.4

Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -1,578.58x
Max industry PE 114.43x
Median industry PE 39.76x
Average industry PE -96.64x



You may also like the below Video Courses